Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma

NCT03453021 · clinicaltrials.gov ↗

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Asthma; Eosinophilic

Interventions

DRUG: Mepolizumab

Sponsor

University Hospital, Grenoble